BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

796 related articles for article (PubMed ID: 15321837)

  • 1. Genetic causes of monogenic heterozygous familial hypercholesterolemia: a HuGE prevalence review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):407-20. PubMed ID: 15321837
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The molecular genetic basis and diagnosis of familial hypercholesterolemia in Denmark.
    Jensen HK
    Dan Med Bull; 2002 Nov; 49(4):318-45. PubMed ID: 12553167
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Portuguese Familial Hypercholesterolemia Study: presentation of the study and preliminary results.
    Bourbon M; Rato Q;
    Rev Port Cardiol; 2006 Nov; 25(11):999-1013. PubMed ID: 17274457
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Chinese homozygote of familial hypercholesterolemia: identification of a novel C263R mutation in the LDL receptor gene.
    Wang D; Wu B; Li Y; Heng W; Zhong H; Mu Y; Wang J
    J Hum Genet; 2001; 46(3):152-4. PubMed ID: 11310584
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Familial hypercholesterolemia and coronary heart disease: a HuGE association review.
    Austin MA; Hutter CM; Zimmern RL; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):421-9. PubMed ID: 15321838
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low density lipoprotein receptor (LDLR) gene mutations in Canadian subjects with familial hypercholesterolemia, but not of French descent.
    Wang J; Huff E; Janecka L; Hegele RA
    Hum Mutat; 2001 Oct; 18(4):359. PubMed ID: 11668627
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Spectrum of LDLR gene mutations, including a novel mutation causing familial hypercholesterolaemia, in North-western Greece.
    Diakou M; Miltiadous G; Xenophontos SL; Manoli P; Cariolou MA; Elisaf M
    Eur J Intern Med; 2011 Oct; 22(5):e55-9. PubMed ID: 21925044
    [TBL] [Abstract][Full Text] [Related]  

  • 8. LDL-receptor mutations in Europe.
    Dedoussis GV; Schmidt H; Genschel J
    Hum Mutat; 2004 Dec; 24(6):443-59. PubMed ID: 15523646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel LDLR mutation, H190Y, in a Utah kindred with familial hypercholesterolemia.
    Hopkins PN; Wu LL; Stephenson SH; Xin Y; Katsumata H; Nobe Y; Nakajima T; Hirayama T; Emi M; Williams RR
    J Hum Genet; 1999; 44(6):364-7. PubMed ID: 10570905
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Familial hypercholesterolemia: epidemiology, Neolithic origins and modern geographic distribution.
    Liyanage KE; Burnett JR; Hooper AJ; van Bockxmeer FM
    Crit Rev Clin Lab Sci; 2011; 48(1):1-18. PubMed ID: 21657943
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Identification of a novel mutation at the point of low density lipoprotein receptor gene from a subject with familial hypercholesterolemia].
    Liu YR; Tao QM; Chen JZ; Tao M; Guo XG; Shang YP; Zhu JH; Zhang FR; Zheng LR; Wang XX
    Sheng Li Xue Bao; 2004 Oct; 56(5):566-72. PubMed ID: 15497035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of LDL receptor gene mutations and the R3500Q mutation of the apoB gene on lipoprotein phenotype of familial hypercholesterolemic patients from a South European population.
    Real JT; Chaves FJ; Ejarque I; García-García AB; Valldecabres C; Ascaso JF; Armengod ME; Carmena R
    Eur J Hum Genet; 2003 Dec; 11(12):959-65. PubMed ID: 14508510
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Genetic aspects of familial hypercholesterolemia and its diagnosis.
    Motulsky AG
    Arteriosclerosis; 1989; 9(1 Suppl):I3-7. PubMed ID: 2563220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of the denaturing gradient gel electrophoresis (DGGE) method for mutational screening of patients with familial hypercholesterolaemia (FH) and Familial defective apolipoprotein B100 (FDB).
    Azian M; Hapizah MN; Khalid BA; Khalid Y; Rosli A; Jamal R
    Malays J Pathol; 2006 Jun; 28(1):7-15. PubMed ID: 17694954
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Familial hypercholesterolemia, peripheral arterial disease, and stroke: a HuGE minireview.
    Hutter CM; Austin MA; Humphries SE
    Am J Epidemiol; 2004 Sep; 160(5):430-5. PubMed ID: 15321839
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of genetic versus clinical diagnosis in familial hypercholesterolemia.
    Civeira F; Ros E; Jarauta E; Plana N; Zambon D; Puzo J; Martinez de Esteban JP; Ferrando J; Zabala S; Almagro F; Gimeno JA; Masana L; Pocovi M
    Am J Cardiol; 2008 Nov; 102(9):1187-93, 1193.e1. PubMed ID: 18940289
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical, diagnostic, and therapeutic aspects of familial hypercholesterolemia.
    van Aalst-Cohen ES; Jansen AC; de Jongh S; de Sauvage Nolting PR; Kastelein JJ
    Semin Vasc Med; 2004 Feb; 4(1):31-41. PubMed ID: 15199431
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations.
    Tybjaerg-Hansen A; Jensen HK; Benn M; Steffensen R; Jensen G; Nordestgaard BG
    Arterioscler Thromb Vasc Biol; 2005 Jan; 25(1):211-5. PubMed ID: 15528480
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization and geographic distribution of the low density lipoprotein receptor (LDLR) gene mutations in northwestern Greece.
    Miltiadous G; Elisaf M; Bairaktari H; Xenophontos SL; Manoli P; Cariolou MA
    Hum Mutat; 2001 May; 17(5):432-3. PubMed ID: 11317361
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Moderate phenotypic expression of familial hypercholesterolemia in Tunisia.
    Jelassi A; Slimani A; Jguirim I; Najah M; Abid A; Boughamoura L; Mzid J; Fkih M; Maatouk F; Rouis M; Varret M; Slimane MN
    Clin Chim Acta; 2010 May; 411(9-10):735-8. PubMed ID: 20144596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 40.